Trials / Completed
CompletedNCT00537550
Adult ALL Treatment at Diagnosis
GIMEMA Guidelines for the Treatment of Adult ALL Affected Patients at Diagnosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto · Academic / Other
- Sex
- All
- Age
- 14 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The present study has been designed to give participating centers the possibility of better understanding the diagnostic and prognostic factors of ALL patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vincristine | Steroids pre-treatment |
| DRUG | Vincristin, Daunorubicine, Asparaginase, Methotrexate | Induction therapy |
Timeline
- Start date
- 2000-07-01
- Completion
- 2006-06-01
- First posted
- 2007-10-01
- Last updated
- 2007-10-01
Locations
5 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00537550. Inclusion in this directory is not an endorsement.